Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

ATNT-12PHASE I, TWO-STAGE, OPEN-LABEL, DOSE-ESCALATION STUDY OF BUPARLISIB (BKM120) IN COMBINATION WITH ADJUVANT TEMOZOLOMIDE (TMZ) AND WITH CONCOMITANT RADIATION THERAPY (RT) AND TMZ IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)

Identifieur interne : 003219 ( Main/Exploration ); précédent : 003218; suivant : 003220

ATNT-12PHASE I, TWO-STAGE, OPEN-LABEL, DOSE-ESCALATION STUDY OF BUPARLISIB (BKM120) IN COMBINATION WITH ADJUVANT TEMOZOLOMIDE (TMZ) AND WITH CONCOMITANT RADIATION THERAPY (RT) AND TMZ IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)

Auteurs : Jordi Rodon [Espagne] ; Mark Rosenthal [Australie] ; Warren Mason [Canada] ; Pedro Perez Segura [Espagne] ; Joseph T. Beck [États-Unis] ; Holger Hirte [Canada] ; John F. Degroot [États-Unis] ; Lucia Trandafir [France] ; Nathalie Pognan [France] ; Lin Yang [États-Unis] ; Charu Kanwal [États-Unis] ; Patrick Y. Wen [États-Unis]

Source :

RBID : PMC:4638534
Url:
DOI: 10.1093/neuonc/nov205.12
PubMed: NONE
PubMed Central: 4638534


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">ATNT-12
<break></break>
PHASE I, TWO-STAGE, OPEN-LABEL, DOSE-ESCALATION STUDY OF BUPARLISIB (BKM120) IN COMBINATION WITH ADJUVANT TEMOZOLOMIDE (TMZ) AND WITH CONCOMITANT RADIATION THERAPY (RT) AND TMZ IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)</title>
<author>
<name sortKey="Rodon, Jordi" sort="Rodon, Jordi" uniqKey="Rodon J" first="Jordi" last="Rodon">Jordi Rodon</name>
<affiliation wicri:level="3">
<nlm:aff id="sa12-af1">
<addr-line>Hospital Vall d'Hebron, Barcelona, Spain</addr-line>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Vall d'Hebron, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Rosenthal, Mark" sort="Rosenthal, Mark" uniqKey="Rosenthal M" first="Mark" last="Rosenthal">Mark Rosenthal</name>
<affiliation wicri:level="3">
<nlm:aff id="sa12-af2">
<addr-line>Royal Melbourne Hospital, Melbourne, Australia</addr-line>
</nlm:aff>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Royal Melbourne Hospital, Melbourne</wicri:regionArea>
<placeName>
<settlement type="city">Melbourne</settlement>
<region type="état">Victoria (État)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Mason, Warren" sort="Mason, Warren" uniqKey="Mason W" first="Warren" last="Mason">Warren Mason</name>
<affiliation wicri:level="1">
<nlm:aff id="sa12-af3">
<addr-line>Princess Margaret Cancer Centre, Toronto, ON, Canada</addr-line>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Princess Margaret Cancer Centre, Toronto, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Segura, Pedro Perez" sort="Segura, Pedro Perez" uniqKey="Segura P" first="Pedro Perez" last="Segura">Pedro Perez Segura</name>
<affiliation wicri:level="3">
<nlm:aff id="sa12-af4">
<addr-line>Hospital Clínico San Carlos, Madrid, Spain</addr-line>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Clínico San Carlos, Madrid</wicri:regionArea>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Beck, Joseph T" sort="Beck, Joseph T" uniqKey="Beck J" first="Joseph T." last="Beck">Joseph T. Beck</name>
<affiliation wicri:level="2">
<nlm:aff id="sa12-af5">
<addr-line>Highlands Oncology Group, Arizona, USA</addr-line>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Highlands Oncology Group, Arizona</wicri:regionArea>
<placeName>
<region type="state">Arizona</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Hirte, Holger" sort="Hirte, Holger" uniqKey="Hirte H" first="Holger" last="Hirte">Holger Hirte</name>
<affiliation wicri:level="1">
<nlm:aff id="sa12-af6">
<addr-line>The Juravinski Cancer Centre, Ontario, Canada</addr-line>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>The Juravinski Cancer Centre, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Degroot, John F" sort="Degroot, John F" uniqKey="Degroot J" first="John F." last="Degroot">John F. Degroot</name>
<affiliation wicri:level="2">
<nlm:aff id="sa12-af7">
<addr-line>University of Texas/MD Anderson Cancer Center, Houston, TX, USA</addr-line>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>University of Texas/MD Anderson Cancer Center, Houston, TX</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Trandafir, Lucia" sort="Trandafir, Lucia" uniqKey="Trandafir L" first="Lucia" last="Trandafir">Lucia Trandafir</name>
<affiliation wicri:level="3">
<nlm:aff id="sa12-af8">
<addr-line>Novartis Pharma S.A.S, Paris, France</addr-line>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Novartis Pharma S.A.S, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Pognan, Nathalie" sort="Pognan, Nathalie" uniqKey="Pognan N" first="Nathalie" last="Pognan">Nathalie Pognan</name>
<affiliation wicri:level="3">
<nlm:aff id="sa12-af8">
<addr-line>Novartis Pharma S.A.S, Paris, France</addr-line>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Novartis Pharma S.A.S, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Yang, Lin" sort="Yang, Lin" uniqKey="Yang L" first="Lin" last="Yang">Lin Yang</name>
<affiliation wicri:level="2">
<nlm:aff id="sa12-af9">
<addr-line>Novartis Pharmaceuticals Corporation, New Jersey, USA</addr-line>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Novartis Pharmaceuticals Corporation, New Jersey</wicri:regionArea>
<placeName>
<region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Kanwal, Charu" sort="Kanwal, Charu" uniqKey="Kanwal C" first="Charu" last="Kanwal">Charu Kanwal</name>
<affiliation wicri:level="2">
<nlm:aff id="sa12-af9">
<addr-line>Novartis Pharmaceuticals Corporation, New Jersey, USA</addr-line>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Novartis Pharmaceuticals Corporation, New Jersey</wicri:regionArea>
<placeName>
<region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Wen, Patrick Y" sort="Wen, Patrick Y" uniqKey="Wen P" first="Patrick Y." last="Wen">Patrick Y. Wen</name>
<affiliation wicri:level="2">
<nlm:aff id="sa12-af10">
<addr-line>Dana-Farber Cancer Institute, Boston, MA, USA</addr-line>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Dana-Farber Cancer Institute, Boston, MA</wicri:regionArea>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmc">4638534</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4638534</idno>
<idno type="RBID">PMC:4638534</idno>
<idno type="doi">10.1093/neuonc/nov205.12</idno>
<idno type="pmid">NONE</idno>
<date when="2015">2015</date>
<idno type="wicri:Area/Pmc/Corpus">000150</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000150</idno>
<idno type="wicri:Area/Pmc/Curation">000150</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000150</idno>
<idno type="wicri:Area/Pmc/Checkpoint">001205</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">001205</idno>
<idno type="wicri:Area/Ncbi/Merge">005268</idno>
<idno type="wicri:Area/Ncbi/Curation">005268</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">005268</idno>
<idno type="wicri:Area/Main/Merge">003220</idno>
<idno type="wicri:Area/Main/Curation">003219</idno>
<idno type="wicri:Area/Main/Exploration">003219</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">ATNT-12
<break></break>
PHASE I, TWO-STAGE, OPEN-LABEL, DOSE-ESCALATION STUDY OF BUPARLISIB (BKM120) IN COMBINATION WITH ADJUVANT TEMOZOLOMIDE (TMZ) AND WITH CONCOMITANT RADIATION THERAPY (RT) AND TMZ IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)</title>
<author>
<name sortKey="Rodon, Jordi" sort="Rodon, Jordi" uniqKey="Rodon J" first="Jordi" last="Rodon">Jordi Rodon</name>
<affiliation wicri:level="3">
<nlm:aff id="sa12-af1">
<addr-line>Hospital Vall d'Hebron, Barcelona, Spain</addr-line>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Vall d'Hebron, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Rosenthal, Mark" sort="Rosenthal, Mark" uniqKey="Rosenthal M" first="Mark" last="Rosenthal">Mark Rosenthal</name>
<affiliation wicri:level="3">
<nlm:aff id="sa12-af2">
<addr-line>Royal Melbourne Hospital, Melbourne, Australia</addr-line>
</nlm:aff>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Royal Melbourne Hospital, Melbourne</wicri:regionArea>
<placeName>
<settlement type="city">Melbourne</settlement>
<region type="état">Victoria (État)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Mason, Warren" sort="Mason, Warren" uniqKey="Mason W" first="Warren" last="Mason">Warren Mason</name>
<affiliation wicri:level="1">
<nlm:aff id="sa12-af3">
<addr-line>Princess Margaret Cancer Centre, Toronto, ON, Canada</addr-line>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Princess Margaret Cancer Centre, Toronto, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Segura, Pedro Perez" sort="Segura, Pedro Perez" uniqKey="Segura P" first="Pedro Perez" last="Segura">Pedro Perez Segura</name>
<affiliation wicri:level="3">
<nlm:aff id="sa12-af4">
<addr-line>Hospital Clínico San Carlos, Madrid, Spain</addr-line>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Clínico San Carlos, Madrid</wicri:regionArea>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Beck, Joseph T" sort="Beck, Joseph T" uniqKey="Beck J" first="Joseph T." last="Beck">Joseph T. Beck</name>
<affiliation wicri:level="2">
<nlm:aff id="sa12-af5">
<addr-line>Highlands Oncology Group, Arizona, USA</addr-line>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Highlands Oncology Group, Arizona</wicri:regionArea>
<placeName>
<region type="state">Arizona</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Hirte, Holger" sort="Hirte, Holger" uniqKey="Hirte H" first="Holger" last="Hirte">Holger Hirte</name>
<affiliation wicri:level="1">
<nlm:aff id="sa12-af6">
<addr-line>The Juravinski Cancer Centre, Ontario, Canada</addr-line>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>The Juravinski Cancer Centre, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Degroot, John F" sort="Degroot, John F" uniqKey="Degroot J" first="John F." last="Degroot">John F. Degroot</name>
<affiliation wicri:level="2">
<nlm:aff id="sa12-af7">
<addr-line>University of Texas/MD Anderson Cancer Center, Houston, TX, USA</addr-line>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>University of Texas/MD Anderson Cancer Center, Houston, TX</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Trandafir, Lucia" sort="Trandafir, Lucia" uniqKey="Trandafir L" first="Lucia" last="Trandafir">Lucia Trandafir</name>
<affiliation wicri:level="3">
<nlm:aff id="sa12-af8">
<addr-line>Novartis Pharma S.A.S, Paris, France</addr-line>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Novartis Pharma S.A.S, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Pognan, Nathalie" sort="Pognan, Nathalie" uniqKey="Pognan N" first="Nathalie" last="Pognan">Nathalie Pognan</name>
<affiliation wicri:level="3">
<nlm:aff id="sa12-af8">
<addr-line>Novartis Pharma S.A.S, Paris, France</addr-line>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Novartis Pharma S.A.S, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Yang, Lin" sort="Yang, Lin" uniqKey="Yang L" first="Lin" last="Yang">Lin Yang</name>
<affiliation wicri:level="2">
<nlm:aff id="sa12-af9">
<addr-line>Novartis Pharmaceuticals Corporation, New Jersey, USA</addr-line>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Novartis Pharmaceuticals Corporation, New Jersey</wicri:regionArea>
<placeName>
<region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Kanwal, Charu" sort="Kanwal, Charu" uniqKey="Kanwal C" first="Charu" last="Kanwal">Charu Kanwal</name>
<affiliation wicri:level="2">
<nlm:aff id="sa12-af9">
<addr-line>Novartis Pharmaceuticals Corporation, New Jersey, USA</addr-line>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Novartis Pharmaceuticals Corporation, New Jersey</wicri:regionArea>
<placeName>
<region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Wen, Patrick Y" sort="Wen, Patrick Y" uniqKey="Wen P" first="Patrick Y." last="Wen">Patrick Y. Wen</name>
<affiliation wicri:level="2">
<nlm:aff id="sa12-af10">
<addr-line>Dana-Farber Cancer Institute, Boston, MA, USA</addr-line>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Dana-Farber Cancer Institute, Boston, MA</wicri:regionArea>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Neuro-Oncology</title>
<idno type="ISSN">1522-8517</idno>
<idno type="eISSN">1523-5866</idno>
<imprint>
<date when="2015">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
</TEI>
<affiliations>
<list>
<country>
<li>Australie</li>
<li>Canada</li>
<li>Espagne</li>
<li>France</li>
<li>États-Unis</li>
</country>
<region>
<li>Arizona</li>
<li>Catalogne</li>
<li>Communauté de Madrid</li>
<li>Massachusetts</li>
<li>New Jersey</li>
<li>Texas</li>
<li>Victoria (État)</li>
<li>Île-de-France</li>
</region>
<settlement>
<li>Barcelone</li>
<li>Madrid</li>
<li>Melbourne</li>
<li>Paris</li>
</settlement>
</list>
<tree>
<country name="Espagne">
<region name="Catalogne">
<name sortKey="Rodon, Jordi" sort="Rodon, Jordi" uniqKey="Rodon J" first="Jordi" last="Rodon">Jordi Rodon</name>
</region>
<name sortKey="Segura, Pedro Perez" sort="Segura, Pedro Perez" uniqKey="Segura P" first="Pedro Perez" last="Segura">Pedro Perez Segura</name>
</country>
<country name="Australie">
<region name="Victoria (État)">
<name sortKey="Rosenthal, Mark" sort="Rosenthal, Mark" uniqKey="Rosenthal M" first="Mark" last="Rosenthal">Mark Rosenthal</name>
</region>
</country>
<country name="Canada">
<noRegion>
<name sortKey="Mason, Warren" sort="Mason, Warren" uniqKey="Mason W" first="Warren" last="Mason">Warren Mason</name>
</noRegion>
<name sortKey="Hirte, Holger" sort="Hirte, Holger" uniqKey="Hirte H" first="Holger" last="Hirte">Holger Hirte</name>
</country>
<country name="États-Unis">
<region name="Arizona">
<name sortKey="Beck, Joseph T" sort="Beck, Joseph T" uniqKey="Beck J" first="Joseph T." last="Beck">Joseph T. Beck</name>
</region>
<name sortKey="Degroot, John F" sort="Degroot, John F" uniqKey="Degroot J" first="John F." last="Degroot">John F. Degroot</name>
<name sortKey="Kanwal, Charu" sort="Kanwal, Charu" uniqKey="Kanwal C" first="Charu" last="Kanwal">Charu Kanwal</name>
<name sortKey="Wen, Patrick Y" sort="Wen, Patrick Y" uniqKey="Wen P" first="Patrick Y." last="Wen">Patrick Y. Wen</name>
<name sortKey="Yang, Lin" sort="Yang, Lin" uniqKey="Yang L" first="Lin" last="Yang">Lin Yang</name>
</country>
<country name="France">
<region name="Île-de-France">
<name sortKey="Trandafir, Lucia" sort="Trandafir, Lucia" uniqKey="Trandafir L" first="Lucia" last="Trandafir">Lucia Trandafir</name>
</region>
<name sortKey="Pognan, Nathalie" sort="Pognan, Nathalie" uniqKey="Pognan N" first="Nathalie" last="Pognan">Nathalie Pognan</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003219 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003219 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     PMC:4638534
   |texte=   ATNT-12PHASE I, TWO-STAGE, OPEN-LABEL, DOSE-ESCALATION STUDY OF BUPARLISIB (BKM120) IN COMBINATION WITH ADJUVANT TEMOZOLOMIDE (TMZ) AND WITH CONCOMITANT RADIATION THERAPY (RT) AND TMZ IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:NONE" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024